Advertisement

Journal of Endocrinological Investigation

, Volume 20, Issue 6, pp 348–367 | Cite as

Molecular pharmacology of somatostatin receptor subtypes

  • Y. C. Patel
Review Article

Key-words

Somatostatin somatostatin receptor SSTR subtypes 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Brazeau P., Vale W., Burgus R., Ling N., Butcher M., Rivier J., Guillemin R. Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science 179: 77, 1973.PubMedCrossRefGoogle Scholar
  2. 2.
    Pradayrol L., Jornvall H., Mutt V., Ribet A. N-terminally extended somatostatin: the primary structure of somatostatin 28. FEBS Lett. 109: 55, 1980.PubMedCrossRefGoogle Scholar
  3. 3.
    Patel Y.C. General aspects of the biology and function of somatostatin. In: Müller, E.E., Thorner, M.O., Weil, C. (Eds.), The role of somatostatin: basic and clinical aspects of neuroscience series. Springer-Verlag, Berlin, Vol. 4, 1992, pp. 1–16.CrossRefGoogle Scholar
  4. 4.
    Patel Y.C, J-L Liu, A.S. Galanopoulou, D.N. Papachristou. Production, action, and degradation of somatostatin. In: Jefferson L.S., Cherrington A.D. (Eds.), The Handbook of Physiology, The endocrine pancreas and regulation of metabolism, Oxford University Press, N.Y. 1997 (in press).Google Scholar
  5. 5.
    Patel Y.C, O’Neil W. Peptides derived from cleavage of prosomatostatin at carboxy and amino terminal segments: characterization of tissue and secreted forms in the rat. J. Biol. Chem. 263: 745, 1988.PubMedGoogle Scholar
  6. 6.
    Reichlin S. Somatostatin. N. Engl. J. Med. 309: 1495, 1556, 1983.PubMedCrossRefGoogle Scholar
  7. 7.
    Aguila M.C., Dees W.L., Haensly W.E., McCann S.M. Evidence that somatostatin is localized and synthesized in lymphoid organs. Proc. Natl. Acad. Sci. (USA) 88: 11485, 1991.CrossRefGoogle Scholar
  8. 8.
    De Lecea L., Criado J.R., Prospero-Garcia O., Gautvik K.M., Schweitzer P., Danielson P.E., Dunlop C.L.M., Siggins G.R., Henriksen S.J., Sutcliffe J.G. A cortical neuropeptide with neuronal depressant and sleep-modulating properties. Nature 381: 242, 1996.PubMedCrossRefGoogle Scholar
  9. 9.
    Fukusumi S., Kitada C, Takekawa S., Kizawa H., Sakomoto J., Miyamoto M., Hinuma S., Kitano K., Fujino M. Identification and characterization of a novel human corticostatin like peptide. Biochem. Biophys. Res. Commun. 232: 157, 1997.PubMedCrossRefGoogle Scholar
  10. 10.
    Kanatsuka A., Makino H., Matsushima Y., Kasanuki J., Osegawa M., Kumagai A. Effect of calcium on the secretion of somatostatin and insulin from pancreatic islets. Endocrinology 108: 22547, 1981.CrossRefGoogle Scholar
  11. 11.
    Montminy M.R., Low M.J., Tapia-Arancibia L., Reichlin S., Mandel G., Goodman R.H. Cyclic AMP regulates somatostatin mRNA accumulation in primary diencephalic cultures and in transfected fibroblast cells. J. Neurosci. 6: 1171, 1986.PubMedGoogle Scholar
  12. 12.
    Patel Y.C, Papachristou D.N., Zingg H.H., Farkas E.M. Regulation of islet somatostatin secretion and gene expression: selective effects of adenosine 3′, 5′ monophosphate and phorbol esters in normal islets of Langerhans and in a somatostatin producing rat islet clonal cell line 1027B2. Endocrinology 128: 1754, 1991.PubMedCrossRefGoogle Scholar
  13. 13.
    Aguila M.C. Growth hormone-releasing factor increases somatostatin release and mRNA levels in the rat periventricular nucleus via nitric oxide by activation of guanylate cyclase. Proc. Natl. Acad. Sci. (USA) 91: 782, 1994.CrossRefGoogle Scholar
  14. 14.
    Patel Y.C, Greenwood M.T., Panetta R., Demchyshyn L, Niznik H., Srikant C.B. Mini Review: The somatostatin receptor family. Life Sciences 57: 1249, 1995.PubMedCrossRefGoogle Scholar
  15. 15.
    Reisine T., Bell G.I. Molecular biology of somatostatin receptors. Endocrinol. Rev. 16: 427, 1995.Google Scholar
  16. 16.
    Epelbaum J., Dournaud P., Fodor M., Viollet C. The neurobiology of somatostatin. Crit. Rev. Neurobiol. 8: 25, 1994.PubMedGoogle Scholar
  17. 17.
    Patel Y.C, Greenwood M.T., Panetta R., Hukovic N., Grigorakis S., Robertson L-A, Srikant C.B. Molecular biology of somatostatin receptor subtypes. Metabolism 45: 31, 1996.PubMedCrossRefGoogle Scholar
  18. 18.
    Da Cunha A., Rausch D.M., Eiden L.E. An early increase in somatostatin mRNA expression in the frontal cortex of Rhesus monkeys infected with simian immunodeficiency virus. Proc. Natl. Acad. Sci. (USA) 92: 1371, 1995.CrossRefGoogle Scholar
  19. 19.
    Hoyer D., Lubbert H., Bruns C. Molecular pharmacology of somatostatin receptors. Arch. Pharmacol. 850: 441, 1994.Google Scholar
  20. 20.
    Violett C, Prevost G., Maubert E., Faivre-Bauman A., Gardette R., Kordon C, Loudes C, Slama A., Epelbaum J. Molecular pharmacology of somatostatin receptors. Fundam. Clin. Pharmacol. 9: 107, 1995.CrossRefGoogle Scholar
  21. 21.
    Lamberts S.W.J., Van Der Lely A-J., de Herder W.W. Drug therapy: octreotide. N. Engl. J. Med. 334: 246, 1996.PubMedCrossRefGoogle Scholar
  22. 22.
    Patel Y.C, Murthy K.K., Escher E., Banville D., Spiess J., Srikant C.B. Mechanism of action of somatostatin: an overview of receptor function and studies of the molecular characterization and purification of somatostatin receptor proteins. Metabolism 39(Suppl. 2): 63, 1990.PubMedCrossRefGoogle Scholar
  23. 23.
    Schonbrunn A., Tashjian A.H. Jr. Characterization of functional receptors for somatostatin in rat pituitary cells in culture. J. Biol. Chem. 253: 6473, 1978.PubMedGoogle Scholar
  24. 24.
    Srikant C.B., Patel Y.C. Somatostatin receptors: identification and characterization in rat brain membranes. Proc. Natl. Acad. Sci. (USA) 78: 3930, 1981.CrossRefGoogle Scholar
  25. 25.
    Srikant C.B., Patel Y.C Receptor binding of somatostatin-28 is tissue specific. Nature 294: 259, 1981.PubMedCrossRefGoogle Scholar
  26. 26.
    Reubi J-C., Cortes R., Maurer R., Probst A., Palacios J.M. Distribution of somatostatin receptors in the human brain: an autoradiographic study. Neuroscience. 18: 329, 1986.PubMedCrossRefGoogle Scholar
  27. 27.
    Thermos, K., Reisine T. Somatostatin receptor subtypes in the clonal anterior pituitary cell lines AtT-20 and GH3. Mol. Pharmacol. 33: 370, 1988.PubMedGoogle Scholar
  28. 28.
    Srikant C.B., Murthy K.K., Escher E., Patel Y.C. Photoaffinity labelling of the somatostatin receptor: Identification of molecular subtypes. Endocrinology 130: 2937, 1992.PubMedGoogle Scholar
  29. 29.
    Brown P.J., Lee A.B., Norman M.G., Presky D.H., Schonbrunn A. Identification of somatostatin receptors by covalent labeling with a novel photoreactive somatostatin analog. J. Biol. Chem. 265: 17995, 1990.PubMedGoogle Scholar
  30. 30.
    He H.T., Johnson K., Thermos K., Reisine T. Purification of a putative brain somatostatin receptor. Proc. Natl. Acad. Sci. (USA) 86: 1480, 1989.CrossRefGoogle Scholar
  31. 31.
    Eppler CM., Zysk J.R., Corbett M., Shieh H-M. Purification of a pituitary receptor for somatostatin. The utility of biotinylated somatostatin analogs. J. Biol. Chem. 267: 15603, 1992.PubMedGoogle Scholar
  32. 32.
    Maletti M., Andersson M., Marie J-C, Rosselin G., Mutt V. Solubilization and partial purification of somatostatin-28 preferring receptors from hamster pancreatic beta cells. J. Biol. Chem. 267: 15620, 1992.PubMedGoogle Scholar
  33. 33.
    Sullivan S.J., Schonbrunn A. Distribution of somatostatin receptors in RINm5F insulinoma cells. Endocrinology 122: 1137, 1988.PubMedCrossRefGoogle Scholar
  34. 34.
    Liebow C, Reilly C, Serrano M., Schally A.V. Somatostatin analogues inhibit growth of pancreatic cancer by stimulating tyrosine phosphatase. Proc. Natl. Acad. Sci. (USA) 86: 2003, 1989.CrossRefGoogle Scholar
  35. 35.
    Zeggari M., Esteve J-P., Rauly I., Cambillau C, Mazarguil H., Dufresne M., Pradayrol L, Chayvialle J-A., Vaaysse N., Susini C. Copurification of a protein tyrosine phosphatase with activated somatostatin receptors from rat pancreatic acinar membranes. Biochem. J. 303: 441, 1994.PubMedCentralPubMedGoogle Scholar
  36. 36.
    Pagliacci M.C, Tognellinin R., Grignani F., Nicoletti F. Inhibition of human breast cancer cell (MCF-7) growth in vitro by the somatostatin analog SMS201-995: effects on cell cycle parameters and apoptotic cell death. Endocrinology 129: 2555, 1991.PubMedCrossRefGoogle Scholar
  37. 37.
    Nilsson L., Folkesson R. Coexistence of somatostatin receptor subtypes in the human neuroblastoma cell line LA-N-2. FEBS Lett. 401: 838, 1997.CrossRefGoogle Scholar
  38. 38.
    Feindt J., Becker I., Blomer U., Hugo H.H., Mehdorn H.M., Kritsch B., Mentlein R. Expression of somatostatin receptor subtypes in cultured astrocytes and gliomas. J. Neurochem. 65: 1997, 1995.PubMedCrossRefGoogle Scholar
  39. 39.
    Sreedharan S.P., Kodama K.T., Peterson K.E., Goetzl E.J. Distinct subsets of somatostatin receptors on cultured human lymphocytes. J. Biol. Chem. 264: 949, 1989.PubMedGoogle Scholar
  40. 40.
    Yamada Y., Post S.R., Wang K., Tager H.S., Bell G.I., Seino S. Cloning and functional characterization of a family of human and mouse somatostatin receptors expressed in brain, gastrointestinal tract, and kidney. Proc. Natl. Acad. Sci. (USA) 89: 251, 1992.CrossRefGoogle Scholar
  41. 41.
    Kluxen F.W., Bruns CH., Lubbert H. Expression cloning of a rat brain somatostatin receptor cDNA. Proc. Natl. Acad. Sci. (USA) 39: 4618, 1992.CrossRefGoogle Scholar
  42. 42.
    Li X-J., Forte M., North R.A., Ross C.A., Snyder S.H. Cloning and expression of a rat somatostatin receptor enriched in brain. J. Biol. Chem. 267: 21307, 1992.PubMedGoogle Scholar
  43. 43.
    Yasuda K., Rens-Domiano S., Breder C.D., Law S.F, Saper C.B., Reisine T., Bell G.I. Cloning of a novel somatostatin receptor, SSTR3, coupled to adenylyl cyclase. J. Biol. Chem. 267: 20422, 1992.PubMedGoogle Scholar
  44. 44.
    Meyerhof W., Wulfsen I., Schonrock C, Fehr S., Richter D. Molecular cloning of a somatostatin-28 receptor and comparison of its expression pattern with that of a somatostatin 14 receptor in rat brain. Proc. Natl. Acad. Sci. (USA) 89: 10267, 1992.CrossRefGoogle Scholar
  45. 45.
    Yamada Y., Reisine T., Law S.F., Ihara Y., Kubota A., Kagimoto S., Seino M., Seino Y., Bell G.I., Seino S. Somatostatin receptors, an expanding gene family: cloning and functional characterization of human SSTR3, a protein coupled to adenylate cyclase. Mol. Endocrinol. 6: 2136, 1992.PubMedGoogle Scholar
  46. 46.
    Bruno J.F., Xu Y., Song J., Berelowitz M. Molecular cloning and functional expression of a brain-specific somatostatin receptor. Proc. Natl. Acad. Sci. (USA) 89: 11151, 1992.CrossRefGoogle Scholar
  47. 47.
    Rohrer L, Raulf F., Bruns C, Buettner R., Hofstaedter F., Schule R. Cloning and characterization of a fourth human somatostatin receptor. Proc. Natl. Acad. Sci. (USA) 90: 4196, 1993.CrossRefGoogle Scholar
  48. 48.
    Demchyshyn L.L., Srikant C.B., Sunahara R.K., Kent G., Seeman P., Van Tol H.H.M., Panetta R., Patel Y.C., Niznik H.B. Cloning and expression of a human somatostatin-14 selective receptor variant (SSTR4) located on chromosome 20. Mol. Pharmacol. 43: 894, 1993.PubMedGoogle Scholar
  49. 49.
    Corness J.D., Demchyshyn L.L, Seeman P., Van Tol H.H.M., Srikant C.B., Kent G., Patel Y.C, Niznik H.B. A human somatostatin receptor (SSTR3), located on chromosome 22, displays preferential affinity for somatostatin-14 like peptides. FEBS Lett. 321: 279, 1993.PubMedCrossRefGoogle Scholar
  50. 50.
    O’Carroll A.M., Lolait S.J., König M., Mahan L.C. Molecular cloning and expression of a pituitary somatostatin receptor with preferential affinity for somatostatins. Mol. Pharmacol. 42: 939, 1992.PubMedGoogle Scholar
  51. 51.
    Panetta R., Greenwood M.T., Warszynska A., Demchyshyn L.L., Day R., Niznik H.B., Srikant C.B., Patel Y.C. Molecular cloning, functional characterization, and chromosomal localization of a human somatostatin receptor (somatostatin receptor type 5) with preferential affinity for somatostatin-28. Mol. Pharmacol. 45: 417, 1994.PubMedGoogle Scholar
  52. 52.
    Vanetti M., Kouba M., Wang X., Vogt G., Hollt V. Cloning and expression of a novel mouse somatostatin receptor (SSTR2B). FEBS Lett. 311: 290, 1992.PubMedCrossRefGoogle Scholar
  53. 53.
    Patel Y.C, Greenwood M.T., Kent G., Panetta R., Srikant C.B. multiple gene transcripts of the somatostatin receptor SSTR2: tissue selective distribution and cAMP regulation. Biochem. Biophys. Res. Commun. 192: 28, 1993.CrossRefGoogle Scholar
  54. 54.
    Evans C.J., Keith D.E. Jr., Morrison H., Magendzo K., Edwards R.H. Cloning of a delta opioid receptor by functional expression. Science 258: 1952, 1992.PubMedCrossRefGoogle Scholar
  55. 55.
    Wilson R., Ainscough R., Anderson K., Baaynes C., Berks M., Bonfield J., Burton J., Connell M., Copsey T., Cooper J. et al. Nature 368: 32, 1994.PubMedCrossRefGoogle Scholar
  56. 56.
    Jung B.P., Nguyen T., Kolakowski L.F. Jr., Lynch K.R., Heng H.H.Q., George S.R., O’Dowd B.F. Discovery of a novel human G protein coupled receptor gene (GPR25) located on chromosome 1. Biochem. Biophys. Res. Commun. 230: 69, 1997.PubMedCrossRefGoogle Scholar
  57. 57.
    Kolakowski F.L., Jung B.P., Nguyen T., Johnson M.P., Lynch K.R., Cheng R., Heng H.H.Q., George S.R., O’Dowd B.F. Characterization of a human gene related to genes encoding somatostatin receptors. FEBS Lett. 303: 253, 1996.CrossRefGoogle Scholar
  58. 58.
    Veber D., Saperstein R., Nutt R., Friedinger R., Brady S., Curley P., Perlow D., Palveda W., Colton C, Zacchei A., Tocco D., Hoff D., Vandlen R., Gerich J., Hall L., Mandarino L., Cordes E., Anderson P., Hirschmann R. A superactive cyclic hexapeptide analog of somatostatin. Life Sci. 34: 1371, 1984.PubMedCrossRefGoogle Scholar
  59. 59.
    Bauer W., Briner U., Doepfner W., Halber R., Huguenin R., Marbach P., Petcher T.J., Pless J. SMS 201–995: a very potent and selective octapeptide analogue of somatostatin with prolonged action. Life Sci. 37: 1133, 1982.CrossRefGoogle Scholar
  60. 60.
    Taylor J.E., Bogden A.E., Moreau J.-P., Coy D.H. In vitro and in vivo inhibition of human small cell lung carcinoma (NCI-H69) growth by a somatostatin analogue. Biochem. Biophys. Res. Commun. 153: 81, 1988.PubMedCrossRefGoogle Scholar
  61. 61.
    Raynor K., Murphy W.A., Coy D.H., Taylor J.E., Moreau J.-P., Yasuda K., Bell G.I., Reisine T. Cloned somatostatin receptors: identification of subtype-selective peptides and demonstration of high affinity binding of linea peptides. Mol. Pharmacol. 43: 838, 1993PubMedGoogle Scholar
  62. 62.
    Patel Y.C, Srikant C.B. Subtype selectivity of peptide analogs for all five cloned human somatostatin receptors (hsstrl-5). Endocrinology 735: 2814, 1994.Google Scholar
  63. 63.
    Bruns C, Raulf F., Hoyer D., Schloos J., Lubbert H., Weckbecker G. Binding properties of somatostatin receptor subtypes. Metabolism 45(Suppl. 1): 17, 1996.PubMedCrossRefGoogle Scholar
  64. 64.
    Shimon I., Taylor J.E., Dong J.Z., Bitonte R.A., Kim S., Morgan B., Coy D.H., Culler M.D, Melmed S. Somatostatin receptor subtype specificity in human fetal pituitary culture. J. Clin. Invest. 99: 789, 1997.PubMedCentralPubMedCrossRefGoogle Scholar
  65. 65.
    Liapakis G., Haeger C, Rivier J., Reisine T. Development of a selective agonist at the somatostatin receptor subtype SSTR1. J. PET 276: 1089, 1996.Google Scholar
  66. 66.
    Bass R.T., Buckwalter B.L., Patel B.P., Pausch M.H., Price L.A., Strnad J., Hadcock J.R. Identification and characterization of novel somatostatin antagonists. Mol. Pharmacol. 50: 709, 1996.PubMedGoogle Scholar
  67. 67.
    Baldwin J.M. Structure and function of receptors coupled to G proteins. Curr. Opin. Cell Biol. 6: 180, 1994.PubMedCrossRefGoogle Scholar
  68. 68.
    Strader C.D., Fong T.M., Graziano M.P., Tota M.R. The family of G protein coupled receptors. FASEB J. 9: 745, 1995.PubMedGoogle Scholar
  69. 69.
    Schwartz T.W., Rosenkilde M.M. Is there a lock for all agonist keys in 7 TM receptors. TIPS 77: 213, 1996.Google Scholar
  70. 70.
    Gether U., Johansen T.E., Snider R.M., Lowe J.A., Edmons-Alt X., Yokota Y., Nakamishi S., Schwartzz T.W. Binding epitopes for peptide and nonpeptide ligands on the NK1 (substance P) receptor. Regul. Pept. 46: 49, 1993.PubMedCrossRefGoogle Scholar
  71. 71.
    Hjorth S.A., Schambye H.T., Greenlee W.J., Schwartz T.W. Identification of peptide binding residues in the extracellular domains of the AT1 receptor. J. Biol. Chem. 269: 30953, 1994.PubMedGoogle Scholar
  72. 72.
    Flanagan CA., Becker I.I., Davidson J.S., Wakefield I.K., Zhou W., Sealfon SC., Miller R.P. Glutamate 301 of the mouse gonadotrophin releasing hormone receptor confers specificity for arginine 8 of mammalian gonadotrophin releasing hormone. J. Biol. Chem. 269: 22636, 1994.PubMedGoogle Scholar
  73. 73.
    Kaupman K., Bruns C, Raulf F., Weber H.P., Mattes H., Lubbert H. Two amino acids, located in transmembrane domains VI and VII, determine the selectivity of the peptide agonist SMS201-995 for the SSTR2 somatostatin receptor. EMBO J. 14: 727, 1995.Google Scholar
  74. 74.
    Nehring R.B., Meyerhof W., Richter D. Aspartic acid residue 124 in the third transmembrane domain of the somatostatin receptor subtype 3 is essential for somatostatin 14 binding. DNA and Cell Biol. 14: 939, 1995.CrossRefGoogle Scholar
  75. 75.
    Strnad J., Hadcock J.R. Identification of a critical aspartate residue in transmembrane domain three necessary for the binding of somatostatin to the somatostatin receptor SSTR2. Biochem. Biophys. Res. Commun. 276: 913, 1995.CrossRefGoogle Scholar
  76. 76.
    Fitz-Patrick V.D., Vandlen R.L 6 agonist selectivity determinants in somatostatin receptor subtypes I and II. J. Biol. Chem. 269: 24621, 1994.Google Scholar
  77. 77.
    Greenwood M.T., Hukovic N., Kumar U., Panetta R., Hjorth S.A., Srikant C.B., Patel Y.C Ligand binding pocket of the human somatostatin receptor 5 (hsstr5): mutational analysis of the extracellular domains. Mol. Pharmacol. 1997 (in press).Google Scholar
  78. 78.
    Luthin D.R., Eppler CM., Linden J. Identification and quantification of Gi-type GTPbinding proteins that copurify with a pituitary somatostatin receptor. J. Biol. Chem. 268: 5990, 1993.PubMedGoogle Scholar
  79. 79.
    Law S.F., Yasuda K., Bell G.I., Reisine T. Gi alpha 3 and G (o) alpha selectively associate with cloned somatostatin in receptor subtypes SSTR2. J. Biol. Chem. 268: 10721, 1993.PubMedGoogle Scholar
  80. 80.
    Tallent M., and Reisine T. Gi alpha 1 selectively couples somatostatin receptors to adenylyl cyclase in pituitary-derived AtT-20 cells. Mol. Pharmacol. 41: 452, 1992.PubMedGoogle Scholar
  81. 81.
    Liu Y.F., Jacobs K.H., Rosewick M.M., Albert P.R. G protein specificity in receptor effector coupling: analysis of the roles of Go and Gi in GH4CI pituitary cells. J. Biol. Chem. 269: 13880, 1994.PubMedGoogle Scholar
  82. 82.
    Senogles S.E. The D2 dopamine receptor isoforms signal through distinct Gi alpha proteins to inhibit adenylyl cyclase. A study with site-directed mutant Gi alpha proteins. J. Biol. Chem. 269: 23120, 1994.PubMedGoogle Scholar
  83. 83.
    Wang H.L., Bogen C, Reisine T., Dichter M. Somatostatin-14 and somatostatin-28 induce opposite effects on potassium currents in rat neocortical neurons. Proc. Natl. Acad. Sei. (USA) 86: 9616, 1989.CrossRefGoogle Scholar
  84. 84.
    Sims S.M., Lussier BT., Kraicer J. Somatostatin activates an inwardly rectifying K+ conductance in freshly dispersed rat somatotrophs. J. Physiol. 441: 615, 1991.PubMedCentralPubMedGoogle Scholar
  85. 85.
    De Weille J.R., Schmid-Antomarchi H., Fosset M., Lazdunski M. Regulation of ATPsensitive K+ channels in insulinoma cells: activation by somatostatin and protein kinase C and the role of cAMP. Proc. Natl. Acad. Sci. (USA) 86: 2971, 1989.CrossRefGoogle Scholar
  86. 86.
    White R.E., Schonbrunn A., Armstrong D.L. Somatostatin stimulates Ca2+ -activated K+ channels through protein dephosphorylation. Nature 351: 570, 1991.PubMedCrossRefGoogle Scholar
  87. 87.
    Yatani A., Codina J., Sekura R.D., Birnbaumer L., Brown A.M. Reconstitution of somatostatin and muscarinic receptor mediated stimulation of K+ channels by isolated GK protein in clonal rat anterior pituitary cell membranes. Mol. Endocrinol. 1: 283, 1987.PubMedCrossRefGoogle Scholar
  88. 88.
    Koch B.D., Schonbrunn A. Characterization of the cyclic AMP-independent actions of somatostatin in GH cells. J. Biol. Chem. 263: 226, 1988.PubMedGoogle Scholar
  89. 89.
    Ikeda S.R., Schofield G.G. Somatostatin blocks a calcium current in rat sympathetic ganglion neurons. J. Physiol. 469: 221, 1989.Google Scholar
  90. 90.
    Kleuss C, Heschefeler J., Ewel C, Rosenthal W., Schultz G., Wittig B. Assignment of G protein subtypes to specific receptors inducing inhibition of calcium currents. Nature 353: 43, 1991.PubMedCrossRefGoogle Scholar
  91. 91.
    Meriney S.D., Gray D.B., Pilar G.R. Somatostatin-induced inhibition of neuronal Ca2+ current modulated by cGMP-dependent protein kinase. Nature 369: 336, 1994.PubMedCrossRefGoogle Scholar
  92. 92.
    Renstrom E., Ding W-G., Bokvist K., Rorsman P. Neurotransmitter-induced inhibition of exocytosis in insulin-secreting β cells by activation of calcineurin. Neuron 17: 513, 1996.PubMedCrossRefGoogle Scholar
  93. 93.
    Barber, D.L., M.E. McGuire, M.B. Ganz. Beta-adrenergic and somatostatin receptors regulate Na-H exchange independent of cAMP. J. Biol. Chem. 264: 21038, 1989.PubMedGoogle Scholar
  94. 94.
    Schweitzer R., Madamba S., Siggins G.R. Arachidonic acid metabolites as mediators of somatostatin-induced increase of neuronal M-current. Nature 346: 464, 1990.PubMedCrossRefGoogle Scholar
  95. 95.
    Schonbrunn A. Somatostatin action in pituitary cells involves two independent transduction mechanisms. Metabolism 39(Suppl. 2): 96, 1990.PubMedCrossRefGoogle Scholar
  96. 96.
    Brown P., Schonbrunn A. Affinity purification of a somatostatin receptor-G-protein complex demonstrates specificity in receptor-G-protein coupling. J. Biol. Chem. 268: 6668, 1993.PubMedGoogle Scholar
  97. 97.
    Patel Y.C, Greenwood M.T., Warszynska A., Panetta R., Srikant C.B. All five cloned human somatostatin receptors (hSSTR1-5) are functionally coupled to adenylyl cyclase. Biochem. Biophys. Res. Commun. 798: 605, 1994.CrossRefGoogle Scholar
  98. 98.
    Florio T., Rim C, Hershberger R.E., Loda M., Stork P.J. The somatostatin receptor SSTR1 is coupled to phosphotyrosine phosphatase activity in CHO-K1 cells Mol. Endocrinol. 8: 1289, 1994.Google Scholar
  99. 99.
    Buscail L, Esteve J.-P., Saint-Laurent N., Bertrand V., Reisine T., O’Carroll A.-M., Bell G.I., Schally A.V., Vaysse N., Susini C. Inhibition of cell proliferation by the somatostatin analogue RC-160 is mediated by somatostatin receptor subtypes SSTR2 and SSTR5 through different mechanisms. Proc. Natl. Acad. Sci. (USA) 92: 1580, 1995.CrossRefGoogle Scholar
  100. 100.
    Reardon D.B., Wood S.L, Brautigan D.L., Bell G.I., Dent P., Sturgill T.W. Activation of a protein tyrosine phosphate and inactivation of Raf-1 by somatostatin. Biochem. J. 314: 401, 1996.PubMedCentralPubMedGoogle Scholar
  101. 101.
    Florio T., Scarziello A., Fattore M., Dalto V., Salzano S., Rossi G., Berlingieri M.T., Fusco A., Schettini G. Somatostatin inhibits PC C13 thyroid cell proliferation through the modulation of phosphotyrosine phosphatase activity-impairment of the somatostatinergic effects by stable expression of EIA viral oncogene. J. Biol. Chem. 271: 6129, 1996.PubMedCrossRefGoogle Scholar
  102. 102.
    Sharma K., Patel Y.C, Srikant C.B. Subtype selective human somatostatin receptor (hSSTR) mediated cytostatin and cytotoxic actions involve different signalling mechanisms. Program Annual Meeting US Endocrine Society, Minneapolis, June 1997 (abstract).Google Scholar
  103. 103.
    Hou C, Gilbert R.L., Barber D.L. Subtype-specific signalling mechanisms of somatostatin receptors SSTR1 and SSTR2. J. Biol. Chem. 269: 10357, 1994.PubMedGoogle Scholar
  104. 104.
    Fujii Y., Gonoi T., Yamada Y., Chihara K., Inagaki N., Seino S. Somatostatin receptor subtype SSTR2 mediates the inhibition of high voltage activated calcium channels by somatostatin and its analogue SMS201-995. FEBS Lett. 355: 117, 1994.PubMedCrossRefGoogle Scholar
  105. 105.
    Viana F., Hille B. Modulation of high voltage-activated calcium channels by somatostatin in acutely isolated rat amygdaloid neurons. J. Neurosci. 76: 6000, 1996.Google Scholar
  106. 106.
    Bito H., Mori M., Sakanaka C, Takano T., Honda Z., Gotoh Y., Nishida E., Shimizu T. Functional coupling of SSTR4, a major hippocampal somatostatin receptor, to adenylate cyclase inhibition, arachidonate release and activation of the mitogen-activated protein kinase cascade. J.Biol. Chem. 269: 12722, 1994.PubMedGoogle Scholar
  107. 107.
    Akbar M., Okajima F., Tomura H., Majid M.A., Yamada Y., Seino S., Kondo Y. Phospholipase C activation and Ca2+ mobilization by cloned human somatostatin receptor subtypes 1–5 in transfected COS-7 cells. FEBS Lett. 348: 192, 1994.PubMedCrossRefGoogle Scholar
  108. 108.
    Luini A., de Matteis M.A. Evidence that receptor-linked G protein inhibits exocytosis by a post-second messenger mechanism in AtT-20 cells. J. Neurochem. 54: 30, 1990.PubMedCrossRefGoogle Scholar
  109. 109.
    Wollheim C.B., Winiger B.P., Ullrich S., Wuarin F., Schlegel W. Somatostatin inhibition of hormone release: effects on cytosolic Cal and interference with distal secretory events. Metabolism (Suppl. 11) 39: 101, 1990.PubMedCrossRefGoogle Scholar
  110. 110.
    Pan M.G., Florio T., Stork P.J.S. G protein activation of a hormone-stimulated phosphatase in human tumor cells. Science 256: 1215, 1992.PubMedCrossRefGoogle Scholar
  111. 111.
    Srikant C.B., Shen S.H. Octapeptide somatostatin analog SMS 201–995 induces translocation of intracellular PTPIC to membranes in MCF-7 human breast cancer adenocarcinoma cells. Endocrinology 137: 3461, 1996.PubMedGoogle Scholar
  112. 112.
    Srikant C.B. Cell cycle dependent induction of apoptosis by somatostatin analog SMS201995 in AtT-20 mouse pituitary tumor cells. Biochem. Biophys. Res. Commun. 209: 400, 1995.PubMedCrossRefGoogle Scholar
  113. 113.
    Sharma K., Patel Y.C, Srikant C.B. Subtype selective induction of p53-dependent apoptosis but not bell cycle arrest by human somatostatin receptor 3. Mol. Endocrinol. 10: 1688, 1996.PubMedGoogle Scholar
  114. 114.
    Bruno J.F., Xu Y., Song J., Berelowitz M. Tissue distribution of somatostatin receptor subtype messenger ribonucleic acid in the rat. Endocrinology 133: 2561, 1993.PubMedGoogle Scholar
  115. 115.
    Breder C.D., Yamada Y.Y., Yasuda K., Seino S., Saper C.B., Bell G.I. Differential expression of somatostatin receptor subtypes in brain. J. Neurosci. 12: 3920, 1992.PubMedGoogle Scholar
  116. 116.
    Kong H., DePaoli A.M., Breder C.D., Yasuda K., Bell G.I., Reisine T. Differential expression of messenger RNAs for somatostatin receptor subtypes SSTR1, SSTR2, and SSTR3 in adult rat brain: analysis by RNA blotting and in situ hybridization histochemistry. Neuroscience 59: 175, 1994.PubMedCrossRefGoogle Scholar
  117. 117.
    Thoss V.S., Perez J., Duc D., Hoyer D. Embryonic and postnatal mRNA distribution of five somatostatin receptor subtypes in the rat brain. Neuropharmacology 34: 1673, 1995.PubMedCrossRefGoogle Scholar
  118. 118.
    Thoss V.S., Perez J., Probat A., Hoyer D. Expression of five somatostatin receptor mRNAs in the human brain and pituitary. Arch. Pharmacol. 354: 411–419, 1996.CrossRefGoogle Scholar
  119. 119.
    Dournaud P., Gu Y.Z., Schonbrunn A., Mazella J., Tannenbaum G.S., Beaudet A. Localization of the somatostatin receptor SST2A in rat brain using a specific antipeptide antibody. J. Neurosci. 76: 4468, 1996.Google Scholar
  120. 120.
    Patel Y.C, Panetta R., Escher E., Greenwood M., Srikant C.B. Expression of multiple somatostatin receptor genes in AtT-20 cells: evidence for a novel somatostatin-28 selective receptor subtype. J. Biol. Chem. 269: 1506, 1994.PubMedGoogle Scholar
  121. 121.
    Day R., Dong W., Panetta R., Kraicer J., Greenwood M.T., Patel Y.C. Expression of mRNA for somatostatin receptor (sstr) types 2 and 5 in individual rat pituitary cells. A double labeling in situ hybridization analysis. Endocrinology 136: 5232, 1995.PubMedGoogle Scholar
  122. 122.
    O’Carroll A., Krempels K. Widespread distribution of somatostatin receptor messenger ribonucleic acids in rat pituitary. Endocrinology 136: 5224, 1995.PubMedGoogle Scholar
  123. 123.
    Panetta R., Patel Y.C. Expression of mRNA for all 5 human somatostatin receptor (hSSTR1-5) in pituitary tumors. Life Sci. 56: 333, 1994.CrossRefGoogle Scholar
  124. 124.
    Grigorakis S.I., Panetta R., Patel Y.C Expression of mRNA for somatostatin receptor (sstr) subtypes 1–5 in islets and differential down-regulation of sstr2 mRNA by SST agonists. Program Annual Meeting American Diabetes Association, June 10–13, 1995, Atlanta, Georgia, Abstr. no. 485, p. 132A.Google Scholar
  125. 125.
    Amherdt M., Patel Y.C, Orci L. Selective binding of somatostatin-14 and somatostatin −28 to islet cells revealed by quantitative electron microscopic autoradiography. J. Clin. Invest. 80: 1455, 1987.PubMedCentralPubMedCrossRefGoogle Scholar
  126. 126.
    Le Romancer M., Cherifi Y., Levasseur S., Laigneau J.P., Peranzi G., Jois P., Lewin M.J., Reyl-Desmars F. Messenger RNA expression of somatostatin receptor subtypes in human and rat gastric mucosae. Life Sci. 53: 1091, 1996.CrossRefGoogle Scholar
  127. 127.
    Lamberts S.W.J., Krenning E.P., and Reubi J.-C. The role of somatostatin and its analogs in the diagnosis and treatment of tumors. Endocr. Rev. 12: 450, 1991.PubMedCrossRefGoogle Scholar
  128. 128.
    Greenman Y., Melmed S. Heterogeneous expression of two somatostatin receptor subtypes in pituitary tumors. J. Clin. Endocrinol. Metab. 78: 398, 1994.PubMedGoogle Scholar
  129. 129.
    Greenman Y., Melmed S. Expression of three somatostatin receptor subtypes in pituitary adenomas: evidence for preferential SSTR5 expression in the mammosomatotroph lineage. J. Clin. Endocrinol. Metab. 79: 724, 1994.PubMedGoogle Scholar
  130. 130.
    Miller G., Alexander M.J.M., Bikkel H.A. Somatostatin receptor subtype gene expression in pituitary adenomas. J. Clin. Endocrinol. Metab. 80: 1386, 1995.PubMedGoogle Scholar
  131. 131.
    Vikic-Topic S., Reisch K.P., Kvols L.K., Vuk-Pavlovic S. Expression of somatostatin receptor subtypes in breast carcinoma, carcinoid tumor, and renal cell carcinoma. J. Clin. Endocrinol. Metab. 80: 2974, 1995.PubMedGoogle Scholar
  132. 132.
    Kubota A., Yamada Y., Kagimoto S., Shimatsu A., Imamura M., Tsuda K., Imura H., Seino S., Seino Y. Identification of somatostatin receptor subtypes and an implication for the efficacy of somatostatin analogue SMS201-995 in treatment of human endocrine tumors. J. Clin. Invest. 93: 1321, 1994.PubMedCentralPubMedCrossRefGoogle Scholar
  133. 133.
    Epelbaum J., Bertherat J., Prevost G., Kordon C, Meyerhof W., Wulfsen I., Richter D., Plouin P-F. Molecular and pharmacological characterization of somatostatin receptor subtypes in adrenal, extra-adrenal and malignant phaeochromocytomas. J. Clin. Endocrinol. Metab. 80: 1837, 1995.PubMedGoogle Scholar
  134. 134.
    Dutour A., Panetta R., Kumar U., Ouafik L, Furin F., Patel Y.C Expression of somatostatin receptor subtypes (1–5) in human brain tumors. J. Clin. Endocrinol. Metab. 1997 (submitted).Google Scholar
  135. 135.
    Krejs G.J., Orci L., Conlon J.M., Ravazzola M., Davis G.R., Raskin P., Collins S.M., McCarthy D.M., Baetens D., Rubinstein A., Aldor T.A.M., Unger R.H. Somatostatinoma syndrome. N. Engl. J. Med. 301: 285, 1979.PubMedCrossRefGoogle Scholar
  136. 136.
    Dohlman H.G., Thorner J., Caron M.G., Lelkowitz R.J. Model systems for the study of seven transmembrane segment receptors. J. Biol. Chem. 268: 337, 1991.Google Scholar
  137. 137.
    Reisine T.D., Axelrod J. Prolonged somatostatin treatment desensitizes somatostatin’s inhibition of receptor-mediated release of adrenocorticotropin hormone and sensitizes adenylate cyclase. Endocrinology 113: 811, 1983.PubMedCrossRefGoogle Scholar
  138. 138.
    Morel G., Leroux P., Pelletier G. Ultrastructural autoradiographic localization of so-matostatin-28 in the rat pituitary gland. Endocrinology 116: 1615, 1985.PubMedCrossRefGoogle Scholar
  139. 139.
    Amherdt M., Patel Y.C, Orci L. Binding and internalization of somatostatin, insulin, and glucagon by cultured rat islet cells. J. Clin. Invest. 84: 412, 1989.PubMedCentralPubMedCrossRefGoogle Scholar
  140. 140.
    Hofland L.J., Van Koetsveld P.M., Waaijers M., Zzuyderwijkk J., Breeman W.A.P., Lamberts S.W.J. Internalization of the radioiodinated somatostatin analog [125l-Tyr3 ] octreotide by mouse and human pituitary tumor cells: increase by unlabelled octreotide. Endocrinology 136: 3698, 1995.PubMedGoogle Scholar
  141. 141.
    Presky D.H., Schonbrunn A. Somatostatin pretreatment increases the number of somatostatin receptors in GH4C1 pituitary cells and does not reduce cellular responsiveness to somatostatin. J. Biol. Chem. 263: 714, 1988PubMedGoogle Scholar
  142. 142.
    Hukovic N., Panetta R., Kumar U., Patel Y.C. Agonist-dependent regulation of cloned human somatostatin receptor types 1–5 (hSSTR1-5): subtype selective internalization or upregulation. Endocrinology 137: 4046, 1996.PubMedGoogle Scholar
  143. 143.
    Nouel D., Gaudriault G., Houle M., Reisine T., Vincent J-P., Mazella J., Beaudet A. Differential internalization of somatostatin in COS-7 cells transfected with SST1 and SST2 receptor subtypes: a confocal microscopic study using novel fluorescent somatostatin derivatives. Endocrinology 138: 296, 1997.PubMedGoogle Scholar
  144. 144.
    Roth A., Kreienkamp H.J., Nehring R.B., Roosterman D., Meyerhof W., Richter D. Endocytosis of the rat somatostatin receptors — subtype discrimination, ligand specificity and delineation of carboxyterminal positive and negative sequence motifs. DNA and Cell Biology 16: 111, 1997.PubMedCrossRefGoogle Scholar
  145. 145.
    Vidal C, Rauly I., Zeggari M., Delesque N., Esteve J.-P., Saint-Lauient N., Vaysse N., Susini C. Up-regulation of somatostatin receptors by epidermal growth factor and gastrin in pancreatic cancer cells. Mol. Pharmacol. 46: 97, 1994.PubMedGoogle Scholar
  146. 146.
    Bruno J.F., Xu Y., Berelowitz M. Somatostatin regulates somatostatin receptor subtype mRNA expression in GH3 cells. Biochem. Biophys. Res. Commun. 202: 1738, 1994.PubMedCrossRefGoogle Scholar
  147. 147.
    Xu Y., Berelowitz M., Brunod J.F. Dexamethasone regulates somatostatin receptor subtype messenger ribonucleic acid expression in rat pituitary GH4C1 cells. Endocrinology 136: 5070, 1995.PubMedGoogle Scholar
  148. 148.
    Kimura N., Hayafiji C, Konagaye H., Takahashi K. 17β estradiol induces somatostatin (SRIF) inhibition of prolactin release and regulates SRIF receptors in rat anterior pituitary cells. Endocrinology 119: 1028, 1986.PubMedCrossRefGoogle Scholar
  149. 149.
    Xu Y.X., Song J., Berelowitz M., Bruno J.F. Estrogen regulates somatostatin receptor subtype 2 messenger ribonucleic acid expression in human breast cancer cells. Endocrinology 5634, 1996.Google Scholar
  150. 150.
    Visser-Wisselaar H.A., Van Uffelen C.J.C., Van Koetsveld P.M., Lichtenauer Kaligis E.G.R., Waaijers A.M., Uitterlinden P., Movy D.M., Lamberts S.W.J., Hofland L.J. 17β estradiol dependent regulation of somatostatin receptor subtype expression in the 7315 b prolactin secreting rat pituitary tumor in vitro and in vivo. Endocrinology 138: 1180, 1997.PubMedGoogle Scholar
  151. 151.
    James R.A., Sarapura V.D., Bruns C, Raulf F., Dowding J.M., Gordon D.F., Wood W.M., Ridgway EC. Thyroid hormone induced expression of specific somatostatin receptor subtypes correlates with involution of the TtT-97 murine thyrotrope tumor. Endocrinology 138: 719, 1997.PubMedGoogle Scholar
  152. 152.
    Bruno J.F., Xu Y., Song J., Berelowitz M. Pituitary and hypothalamic somatostatin receptor subtype messenger ribonucleic acid expression in the food-deprived and diabetic rat. Endocrinology 135: 1787, 1994.PubMedGoogle Scholar
  153. 153.
    Hauser F., Meyerhof W., Wulfsen I., Schonrock C., Richter D. Sequence analysis of the promoter region of the rat somatostatin receptor subtype 1 gene. FEBS Lett. 345: 225, 1994.PubMedCrossRefGoogle Scholar
  154. 154.
    Greenwood M.T., Robertson L.-A., Patel Y.C. Cloning of the gene encoding the human somatostatin receptor 2: sequence analysis of the 5′ flanking promoter region. Gene 159: 291, 1995.PubMedCrossRefGoogle Scholar
  155. 155.
    Pscherer A., Dorflinger U., Kirfel J., Gawlas K., Ruschoff J., Buettner R., Schule R. The helix-loop-helix transcription factor SEF2 regulates the activity of a novel initiator element in the promoter of the human somatostatin receptor II gene. EMBO J. 15: 6680, 1996.PubMedCentralPubMedGoogle Scholar
  156. 156.
    Xu Y., Bruno J.F., Berelowitz M. Characterization of the proximal region of the rat somatostatin receptor gene, SSTR4. Biochem. Biophys. Res. Commun. 206: 935, 1995.PubMedCrossRefGoogle Scholar
  157. 157.
    Greenwood M.T., Panetta R., Robertson L.A., Liu J-L, Patel Y.C. Sequence analysis of the 5′-flanking promoter region of the human somatostatin receptor 5. Biochem. Biophys. Res. Commun. 205: 1883, 1994.PubMedCrossRefGoogle Scholar
  158. 158.
    Sanford R., Sgotto B., Burn T., Brenner S. The tuberin (TSC2) autosomal dominant polycystic kidney disease (PKD1) and somatostatin type V receptor (SSTR5) genes form a synteny group in the fugu genome. Genomics 38: 84, 1996.CrossRefGoogle Scholar
  159. 159.
    Brassier J., Henske E.P. Loss of the polycystic kidney (PKD 1) region of chromosome 1 6pl 3 in renal cyst cells support a loss of function model for cyst pathogenesis. J. Clin. Invest. 99: 194, 1997.CrossRefGoogle Scholar

Copyright information

© Italian Society of Endocrinology (SIE) 1997

Authors and Affiliations

  • Y. C. Patel
    • 1
  1. 1.Fraser Laboratories, McGill University, Departments of Medicine and Neurology and NeurosurgeryRoyal Victoria Hospital and the Montreal Neurological InstituteMontrealCanada

Personalised recommendations